Memon, Aliza A.Ahmed, HasbanLi, YiWongboonsin, JanewitHundert, JoshuaBenoit, StefanieChaudhari, AdvikaSher, JawadGhimire, PratimaHopkins, RebeccaPatel, JayStegman, MelindaLim, KennethAzzi, JamilSiedlecki, Andrew M.2023-08-302023-08-302022Memon AA, Ahmed H, Li Y, et al. A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury. Kidney Int Rep. 2022;7(12):2714-2717. doi:10.1016/j.ekir.2022.09.003https://hdl.handle.net/1805/35221en-USAttribution-NonCommercial-NoDerivatives 4.0 InternationalCOVID-19SARS-CoV2Acute kidney injuryHemodialysisThrombotic microangiopathyA Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney InjuryArticle